Foundayo Hits UK Private Market | Bermuda News

Eli Lilly’s new oral weight-loss drug, Foundayo, is now available privately in the UK — making it the second GLP-1 tablet on the market and the first in Europe. Designed to tackle both weight management and type two diabetes, it’s priced at £100–£120 monthly, far cheaper than injectables like Mounjaro. While NICE must approve it for NHS access, private prescriptions are already open — offering a major new option for patients seeking effective, affordable treatment. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/942f6244fbf81209